Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stark

Showing results (441-450 of 731) with videos related to

Pageof 74
Sort By:
Strahlentherapie|November 1, 1980
[Clinical experience with daily doses of misonidazole (author's transl)]H D Kogelnik, G Reinartz, T Szepesi, et al.
Ticks and Tick-Borne Diseases|September 21, 2025
Comparison of the number of Lyme neuroborreliosis cases in European Centre for Disease Prevention and Control (ECDC) data and national public surveillance reports, 2018-2023Alexander Davidson, Frederick J Angulo, Julie Davis, et al.
Journal of Medicinal Chemistry|September 29, 1995
Synthesis, X-ray crystallography, and pharmacokinetics of novel azomethine prodrugs of (R)-alpha-methylhistamine: highly potent and selective histamine H3 receptor agonistsM Krause, A Rouleau, H Stark, et al.
Structure (London, England : 1993)|April 29, 1998
The 80S rat liver ribosome at 25 A resolution by electron cryomicroscopy and angular reconstitutionP Dube, M Wieske, H Stark, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1997
Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trialB R Switzer, A H Stark, J R Atwood, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 22, 2010
Search for novel, high affinity histamine H3 receptor ligands with fluorescent propertiesK J Kuder, T Kottke, H Stark, et al.
BMC Public Health|August 2, 2025
Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey studyEmily Colby, L Hannah Gould, Ye Tan, et al.
Ticks and Tick-Borne Diseases|August 13, 2024
Publicly available surveillance data on tick-borne encephalitis in Europe, 2023Frederick J Angulo, Kate Halsby, Alexander Davidson, et al.
Agents and Actions. Supplements|January 1, 1991
The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonistsJ M Arrang, M Garbarg, J C Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonistsH Stark, X Ligneau, B Sadek, et al.
Pageof 74

Showing results (441-450 of 731) with videos related to

Sort By:
Pageof 74
Strahlentherapie|November 1, 1980
[Clinical experience with daily doses of misonidazole (author's transl)]H D Kogelnik, G Reinartz, T Szepesi, et al.
Ticks and Tick-Borne Diseases|September 21, 2025
Comparison of the number of Lyme neuroborreliosis cases in European Centre for Disease Prevention and Control (ECDC) data and national public surveillance reports, 2018-2023Alexander Davidson, Frederick J Angulo, Julie Davis, et al.
Journal of Medicinal Chemistry|September 29, 1995
Synthesis, X-ray crystallography, and pharmacokinetics of novel azomethine prodrugs of (R)-alpha-methylhistamine: highly potent and selective histamine H3 receptor agonistsM Krause, A Rouleau, H Stark, et al.
Structure (London, England : 1993)|April 29, 1998
The 80S rat liver ribosome at 25 A resolution by electron cryomicroscopy and angular reconstitutionP Dube, M Wieske, H Stark, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1997
Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trialB R Switzer, A H Stark, J R Atwood, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 22, 2010
Search for novel, high affinity histamine H3 receptor ligands with fluorescent propertiesK J Kuder, T Kottke, H Stark, et al.
BMC Public Health|August 2, 2025
Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey studyEmily Colby, L Hannah Gould, Ye Tan, et al.
Ticks and Tick-Borne Diseases|August 13, 2024
Publicly available surveillance data on tick-borne encephalitis in Europe, 2023Frederick J Angulo, Kate Halsby, Alexander Davidson, et al.
Agents and Actions. Supplements|January 1, 1991
The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonistsJ M Arrang, M Garbarg, J C Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonistsH Stark, X Ligneau, B Sadek, et al.
Pageof 74